Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03256383
Other study ID # 276
Secondary ID
Status Recruiting
Phase N/A
First received August 18, 2017
Last updated August 18, 2017
Start date July 31, 2017
Est. completion date August 31, 2017

Study information

Verified date August 2017
Source Magellan Diagnostics
Contact Catherine Lufkin
Phone 978-248-4963
Email Catherine.Lufkin@magellandx.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is to supplement our internal data that demonstrates the continued performance of capillary blood samples on Magellan's lead testing systems: LeadCare II, LeadCare Ultra (which have been cleared previously by FDA), and PediaStat, which is an upgraded LeadCare II instrument in development.


Recruitment information / eligibility

Status Recruiting
Enrollment 190
Est. completion date August 31, 2017
Est. primary completion date August 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- healthy subjects who consent to a capillary blood collection

Exclusion Criteria:

- Patients are not currently taking chelating agents, e.g., penicillamine, succimer

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Lead testing
Fingerstick

Locations

Country Name City State
United States Pediatric Associates, Inc. Brockton Massachusetts
United States Pediatrics Associates, Inc Hanson Massachusetts
United States Pediatrics Associates, Inc West Bridgewater Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Magellan Diagnostics

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lead poisoning >10ug/dL lead in whole blood is considered lead poisoning These measurements will be taken to compare the fingerstick data collected in the field with data received through reference method 1 day
See also
  Status Clinical Trial Phase
Completed NCT01573013 - Iron Fortification Trail Using NaFeEDTA in Iron Deficient Lead-exposed Children N/A
Withdrawn NCT00552630 - Penicillamine Chelation for Children With Lead Poisoning Phase 2/Phase 3
Completed NCT00014885 - Bone Lead Levels and College Achievement Scores N/A
Completed NCT00004838 - Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children N/A
Enrolling by invitation NCT05265572 - Evaluation of the Impact of a Personal and Domestic Hygiene Intervention on Lead Exposure in a Community Close to a Mine Dump N/A
Completed NCT01739166 - QI Study of a Practice Facilitator's Impact in Working With Clinics on Improving Dental, Lead & Obesity Measures for Children N/A
Completed NCT00285610 - Early Exposure to Lead and Adult Antisocial Outcomes N/A
Completed NCT00011674 - Early Exposure to Lead and Adolescent Development N/A
Completed NCT00374894 - The Combined Effect of 2,3-Dimercaptosuccinic Acid and Multi-Nutrients on Children in Lead Poisoning N/A
Completed NCT00011661 - Social Network Based Intervention to Reduce Lead Exposure Among Native American Children N/A
Recruiting NCT05950386 - Effects of Lead Exposure on Ferroptosis Pathway
Completed NCT02346188 - Effects of Iron and/or Zinc Supplementation in Mexican School Children Exposed to Lead N/A
Completed NCT00013858 - Environmental Contaminants and Infant Development N/A
Completed NCT00013819 - Exposure, Dose, Body Burden and Health Effects of Lead N/A
Active, not recruiting NCT05744752 - Effects of Allium Sativum and Moringa Oleifera Extract on Dental Enamel N/A
Completed NCT00012480 - Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm N/A
Completed NCT00011726 - Lead Mobilization & Bone Turnover in Pregnancy/Lactation N/A
Completed NCT00023101 - Lead, Endocrine Disruption and Reproductive Outcomes N/A
Terminated NCT04498845 - RECLEAN Pilot Study N/A
Recruiting NCT00926406 - Environmental Exposure to Lead and Its Health Effects on Patients With Maintenance Hemodialysis N/A